Registered Zambia · ZAMRA

Neuroxone Injection

citicoline sodium 250 mg

ZAMRA-HM-23-18 Solution for Injection 250 mg nervous system INN generic

What it does

Citicoline is a supplement that may help improve brain function.

Commonly used for: memory problems, stroke recovery, cognitive impairment

Read more in plain English ↓

Plain-language summary for general understanding - not medical advice. Always follow your pharmacist/doctor.

Ask about this medicine

Answers come only from this medicine's registration record, BNF monograph and interaction data - not medical advice.

Medicine sourcing is available in Kenya only. We don't sell or dispense medicines - licensed pharmacies do.

Sourcing - Kenya only

Registration & product details

Registration no.
ZAMRA-HM-23-18
Registration date
2023-04-17
Expiry date
2028-04-16
Status
Registered/Compliant
Active ingredient
citicoline sodium 250 mg
Strength
250 mg
Pack size
-
Therapeutic class
-
ATC class (WHO)
N06BX - Other psychostimulants and nootropics
Drug group
NERVOUS SYSTEM
RxNorm RxCUI
997602
Manufacturer / MAH
Swiss Parenterals
Applicant / LTR
Swiss Parenterals Ltd.
Country of origin
India
Manufacturer location
G.I, industrial Estate, D.C, Ne, near Mahadev catering, Kerala, bavla, Gujarat 382220, India

Source: Zambia Medicines Regulatory Authority · fetched 2026-03-12 00:01:10 · updated 2026-09-17 03:32:39

Disclaimer: This information is sourced from Zambia Medicines Regulatory Authority (Zambia). Always consult a qualified healthcare professional before using any medication.

About this medicine

Citicoline is a supplement that may help improve brain function.

What it treats

  • memory problems
  • stroke recovery
  • cognitive impairment

How it works

Citicoline supports brain health by providing essential nutrients that help with the production of brain chemicals.

Who it's for

It is suitable for adults who want to support their brain health or are recovering from a stroke.

AI-assisted summary grounded in BNF data - general information only, not medical advice. Always confirm with your pharmacist or doctor.

Clinical monograph: citicoline

BNF-referenced

Citicoline, also known as cytidine diphosphate choline (CDP-choline), is a naturally occurring nucleotide that plays a critical role in the synthesis of phospholipids, which are essential components of cell membranes. It is recognized for its neuroprotective properties and potential to enhance cognitive function, particularly in conditions involving cognitive impairment and neurological disorders.

Indications

  • Cognitive impairment
  • Stroke rehabilitation
  • Alzheimer's disease
  • Head trauma
  • Age-related cognitive decline

Dosage

Children: Refer to the BNF for Children for specific dosing recommendations in paediatric populations.

Adults: Refer to the BNF for appropriate dosing in adults, as it may vary based on the condition being treated.

Mechanism of action

Citicoline serves as a precursor for the synthesis of phosphatidylcholine, a major component of neuronal membranes. It is metabolized into choline and cytidine, both of which contribute to the regeneration of damaged neuronal membranes and promote the release of neurotransmitters. The enhancement of dopaminergic neurotransmission and neuroprotective effects against ischemia and excitotoxicity are also attributed to citicoline.

Pharmacodynamics

Citicoline has been shown to enhance memory and cognitive function, particularly in patients with cognitive deficits. It exerts neuroprotective effects by stabilizing cell membranes, promoting neuronal repair, and enhancing synaptic plasticity. Clinical studies have suggested improvements in attention, memory, and overall cognitive performance in various populations, including those with Alzheimer's disease and stroke.

Pharmacokinetics

Citicoline is well-absorbed following oral administration, with peak plasma concentrations achieved within 1-2 hours. It is rapidly metabolized into its active components, choline and cytidine. The elimination half-life of citicoline is approximately 3 hours, and it is primarily excreted through urine. The drug has good bioavailability and can cross the blood-brain barrier, making it effective for central nervous system conditions.

Adverse effects

  • headache
  • nausea
  • diarrhea
  • insomnia
  • abdominal pain

Precautions

  • Use with caution in patients with a history of hypersensitivity to citicoline or any of its components.
  • Monitor patients with a history of seizures.

Pregnancy

Citicoline should be used during pregnancy only if the potential benefit justifies the potential risk to the fetus. There is limited data on its safety in pregnancy.

Breast-feeding

Citicoline is excreted in human milk; caution should be exercised when administered to nursing women.

Storage

Store at room temperature, away from moisture and heat. Keep out of reach of children.

Formulations

  • oral tablets
  • oral solution

AI-synthesized from BNF references - general information only, not a substitute for professional medical advice or the current BNF. Verify doses with a pharmacist.

Molecular reference: citicoline

PubChem CID 13804

Molecular formula: C14H26N4O11P2

Source: PubChem (NCBI) · pathways from PathBank, Reactome, WikiPathways & PharmGKB.

This drug in other countries

The same active ingredient registered across other registries we cover - including different brands.